招股文件
泰格医药全球发售招股书
2020/07/28
[发售以供认购] – 白色申请表格
2020/07/28
[发售以供认购] – 黄色申请表格
2020/07/28
[发售以供认购] – 绿色申请表格
2020/07/28
2020/07/28
2020/07/28
2020/07/28
2020/07/28
2021年6月,在生命健康和临床研究领域拥有25年经验的James Brook先生加入泰格医药,担任西欧、非洲及巴基斯坦区域负责人。近日我们与James进行一次深入对话,谈论了他对行业的洞见和对新岗位的期许和计划。
泰格医药首席科学官杨见松博士,与您分享为何应将中国纳入您未来的药物全球开发策略中,以及相关的政策和科学解读。
近期,在生命健康和医学研究领域有着丰富经验的Charles Schmidt博士加盟泰格医药,担任拉丁美洲地区负责人。他将负责在该地区广纳英才建立团队,以进一步开展跨国临床研究合作。
Copyright © 2004-2022 tigermed.net All Rights Reserved. 浙ICP备11043991号-1
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.